Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahtee L. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content. Br J Pharmacol. 1975 Nov;55(3):381–385. doi: 10.1111/j.1476-5381.1975.tb06941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borenstein P., Bles G. Effets cliniques et électroencéphalographiques du métoclopramide en psychiatrie. Therapie. 1965 Jul-Aug;20(4):975–995. [PubMed] [Google Scholar]
- Calne D. B., Reid J. L., Vakil S. D., Rao S., Petrie A., Pallis C. A., Gawler J., Thomas P. K., Hilson A. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J. 1971 Sep 25;3(5777):729–732. doi: 10.1136/bmj.3.5777.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Day M. D., Blower P. R. Cardiovascular dopamine receptor stimulation antagonized by metoclopramide. J Pharm Pharmacol. 1975 Apr;27(4):276–278. doi: 10.1111/j.2042-7158.1975.tb10699.x. [DOI] [PubMed] [Google Scholar]
- Kataria M., Traub M., Marsden C. D. Extrapyramidal side-effects of metoclopramide. Lancet. 1978 Dec 9;2(8102):1254–1255. doi: 10.1016/s0140-6736(78)92126-8. [DOI] [PubMed] [Google Scholar]
- Lavy S., Melamed E., Penchas S. Tardive dyskinesia associated with metoclopramide. Br Med J. 1978 Jan 14;1(6105):77–78. doi: 10.1136/bmj.1.6105.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marsden C. D. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias). Mod Trends Neurol. 1975;6:141–166. [PubMed] [Google Scholar]